Mark Pykett News Today

Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. announces that at its Annual General Meeting of Shareholders held today, all proposals were approved.The shareholders approved the...

Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all

Notice to Convene the Annual General Meeting of Shareholders of Pharming Group N.V. Pharming Group N.V. invites its...

Response to Request for Opinion Reappointment non-executive Board members dated 04Mar2023 Dear Sijmen, The Works Council thanks you for the...

Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. announces that the Company’s 2024 Annual General Meeting of Shareholders will be held on Tuesday, May 21, 2024 at 14:30 CEST. The...

Explanatory notes to the agenda for the Annual General Meeting of Shareholders of Pharming Group N.V. on May 21, 2024 ...

RUCONEST® business performed strongly in 2Q 2023; continue to anticipate low single digit annual revenue growth Strong start to U.S. Joenja® launch during 2Q...

Myrtelle Inc. announced updated findings of the open-label phase 1/2 clinical trial of its recombinant adeno-associated virus vector-based investigational gene therapy for Canavan disease, a fatal genetic disorder in children.According to a release from Myrtelle, early data from the first in-human study, which is being conducted at Dayton Children’s Hospital in Ohio, revealed that all eight

Total revenues increased 4% in H1 2022 to US$96.8 million, supported by increases in physicians prescribing and number of patients Strong balance sheet and stable cash flow from RUCONEST providing

Press release content from Business Wire. The AP news staff was not involved in its creation.